# WR: Policy for Device Software Functions and Mobile Medical Applications | FDA creste app or tool for pbmt

**Issue:** #15229  
**Repository:** midnghtsapphire/revvel-standards  
**Created:** 2026-07-06  
**WR Status:** 🟡 In Progress  

## Issue Context

- FDA guidance reference: [Policy for Device Software Functions and Mobile Medical Applications](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-device-software-functions-and-mobile-medical-applications)
- Request intent: create an app/tool for PBMT use cases aligned to FDA policy boundaries.

## Summary

Define a compliance-first PBMT software concept that maps requested features to FDA mobile medical app policy buckets.

## Objective

Produce an implementation-ready plan for a PBMT app/tool that separates:
1. low-risk wellness/administrative software functions that can ship quickly, and
2. features that may trigger device/software oversight and require regulatory review before release.

## Required Bundle

- FDA policy interpretation matrix for proposed PBMT features.
- Product scope split: `Phase 1 (non-device / low-regulatory risk)` and `Phase 2 (regulated device-facing capabilities)`.
- Initial architecture for auditability (decision logging, disclaimers, traceable feature flags).

## Definition of Done

- PBMT feature list is categorized against the linked FDA policy document.
- A go/no-go scope recommendation is documented for MVP release.
- Compliance risks, assumptions, and required legal/regulatory follow-ups are explicitly listed.

## Validation

- Confirm every planned PBMT feature has a policy classification and rationale.
- Confirm no high-risk regulated feature is included in MVP scope without an explicit regulatory workstream.
- Confirm user-facing medical claims are constrained to what policy/legal review permits.

## Blockers

None.

<!-- Market research, BOM, SEO, monetization sections are intentionally absent: BASIC template is for bug/chore/docs/refactor WRs with no product/market surface. Use WR_TEMPLATE_FULL.md only for new products or sellable assets. -->
